Pediatrix Medical Group (NYSE:MD) Hits New 12-Month High – What’s Next?

Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) hit a new 52-week high on Thursday. The company traded as high as $28.67 and last traded at $28.58, with a volume of 43,353 shares. The stock had previously closed at $28.10.

Analyst Upgrades and Downgrades

MD has been the subject of several recent analyst reports. Wall Street Zen raised Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 13th. Jefferies Financial Group lowered Pediatrix Medical Group from a “buy” rating to a “hold” rating and lifted their price target for the stock from $27.00 to $28.00 in a report on Wednesday, August 19th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $25.00 price objective on shares of Pediatrix Medical Group in a research report on Wednesday, August 5th. UBS Group upped their price objective on Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Finally, Truist Financial raised their target price on Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $26.60.

Read Our Latest Stock Analysis on Pediatrix Medical Group

Pediatrix Medical Group Trading Down 0.8%

The firm has a market cap of $2.38 billion, a P/E ratio of 14.03 and a beta of 0.61. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.45. The firm’s 50-day simple moving average is $26.66 and its 200 day simple moving average is $24.95.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The firm had revenue of $487.78 million during the quarter, compared to the consensus estimate of $478.49 million. During the same period in the prior year, the firm earned $0.53 EPS. The company’s revenue was up 4.1% compared to the same quarter last year. As a group, analysts expect that Pediatrix Medical Group, Inc. will post 2.17 earnings per share for the current year.

Hedge Funds Weigh In On Pediatrix Medical Group

Several institutional investors and hedge funds have recently bought and sold shares of the company. Global Retirement Partners LLC purchased a new stake in Pediatrix Medical Group in the second quarter worth $33,000. Nykredit A S purchased a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at $35,000. Signaturefd LLC grew its stake in shares of Pediatrix Medical Group by 301.8% during the 3rd quarter. Signaturefd LLC now owns 2,013 shares of the company’s stock worth $52,000 after acquiring an additional 1,512 shares during the period. Integrated Wealth Concepts LLC bought a new position in shares of Pediatrix Medical Group during the 2nd quarter worth $53,000. Finally, EverSource Wealth Advisors LLC increased its holdings in Pediatrix Medical Group by 77.7% in the 1st quarter. EverSource Wealth Advisors LLC now owns 2,515 shares of the company’s stock worth $54,000 after acquiring an additional 1,100 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

About Pediatrix Medical Group

(Get Free Report)

Pediatrix Medical Group, Inc provides specialized physician-led healthcare services for women, infants and children. The company’s clinical offerings include neonatal and perinatal care, maternal-fetal medicine, pediatric medical subspecialties, pediatric hospitalist services and related services delivered in partnership with hospitals and healthcare systems.

Pediatrix-affiliated physicians and advanced practice providers generally work in hospital-based settings, including neonatal intensive care units, delivery rooms, pediatric units and outpatient practices.

Further Reading

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.